218 related articles for article (PubMed ID: 35356978)
1. Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche.
Zeytin IC; Alkan B; Ozdemir C; Cetinkaya DU; Okur FV
Stem Cells Transl Med; 2022 Mar; 11(3):310-321. PubMed ID: 35356978
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
[TBL] [Abstract][Full Text] [Related]
3. Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow.
Mansour A; Abou-Ezzi G; Sitnicka E; Jacobsen SE; Wakkach A; Blin-Wakkach C
J Exp Med; 2012 Mar; 209(3):537-49. PubMed ID: 22351931
[TBL] [Abstract][Full Text] [Related]
4. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
5. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
6. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.
Capo V; Penna S; Merelli I; Barcella M; Scala S; Basso-Ricci L; Draghici E; Palagano E; Zonari E; Desantis G; Uva P; Cusano R; Sergi Sergi L; Crisafulli L; Moshous D; Stepensky P; Drabko K; Kaya Z; Unal E; Gezdirici A; Menna G; Serafini M; Aiuti A; Locatelli SL; Carlo-Stella C; Schulz AS; Ficara F; Sobacchi C; Gentner B; Villa A
Haematologica; 2021 Jan; 106(1):74-86. PubMed ID: 31949009
[TBL] [Abstract][Full Text] [Related]
7. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells.
Xian X; Moraghebi R; Löfvall H; Fasth A; Henriksen K; Richter J; Woods NB; Moscatelli I
Stem Cell Res Ther; 2020 May; 11(1):179. PubMed ID: 32414402
[TBL] [Abstract][Full Text] [Related]
8. TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.
Chen W; Twaroski K; Eide C; Riddle MJ; Orchard PJ; Tolar J
J Bone Joint Surg Am; 2019 Nov; 101(21):1939-1947. PubMed ID: 31567691
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
de Kruijf EFM; Zuijderduijn R; Stip MC; Fibbe WE; van Pel M
Exp Hematol; 2018 Aug; 64():59-70.e2. PubMed ID: 29775645
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.
Uckan D; Kilic E; Sharafi P; Kazik M; Kaya F; Erdemli E; Can A; Tezcaner A; Kocaefe C
Cytotherapy; 2009; 11(4):392-402. PubMed ID: 19337938
[TBL] [Abstract][Full Text] [Related]
11. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts.
Neri T; Muggeo S; Paulis M; Caldana ME; Crisafulli L; Strina D; Focarelli ML; Faggioli F; Recordati C; Scaramuzza S; Scanziani E; Mantero S; Buracchi C; Sobacchi C; Lombardo A; Naldini L; Vezzoni P; Villa A; Ficara F
Stem Cell Reports; 2015 Oct; 5(4):558-68. PubMed ID: 26344905
[TBL] [Abstract][Full Text] [Related]
12. Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.
Gilchrist AE; Harley BAC
Integr Biol (Camb); 2020 Jul; 12(7):175-187. PubMed ID: 32556172
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity.
Crippa S; Rossella V; Aprile A; Silvestri L; Rivis S; Scaramuzza S; Pirroni S; Avanzini MA; Basso-Ricci L; Hernandez RJ; Zecca M; Marktel S; Ciceri F; Aiuti A; Ferrari G; Bernardo ME
J Clin Invest; 2019 Feb; 129(4):1566-1580. PubMed ID: 30830876
[TBL] [Abstract][Full Text] [Related]
14. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse.
Tondelli B; Blair HC; Guerrini M; Patrene KD; Cassani B; Vezzoni P; Lucchini F
Am J Pathol; 2009 Mar; 174(3):727-35. PubMed ID: 19218349
[TBL] [Abstract][Full Text] [Related]
15. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
[TBL] [Abstract][Full Text] [Related]
16. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization.
Miyamoto K; Yoshida S; Kawasumi M; Hashimoto K; Kimura T; Sato Y; Kobayashi T; Miyauchi Y; Hoshi H; Iwasaki R; Miyamoto H; Hao W; Morioka H; Chiba K; Kobayashi T; Yasuda H; Penninger JM; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2011 Oct; 208(11):2175-81. PubMed ID: 22006978
[TBL] [Abstract][Full Text] [Related]
17. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
[TBL] [Abstract][Full Text] [Related]
18. Intramarrow injection of beta-catenin-activated, but not naive mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow.
Ahn JY; Park G; Shim JS; Lee JW; Oh IH
Exp Mol Med; 2010 Feb; 42(2):122-31. PubMed ID: 20054234
[TBL] [Abstract][Full Text] [Related]
19. PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
Yin X; Hu L; Zhang Y; Zhu C; Cheng H; Xie X; Shi M; Zhu P; Zhao X; Chen W; Zhang L; Arakaki C; Hao S; Wang M; Cao W; Ma S; Zhang XB; Cheng T
Bone Marrow Transplant; 2020 Jun; 55(6):1029-1040. PubMed ID: 31804621
[TBL] [Abstract][Full Text] [Related]
20. Aging-Related Reduced Expression of CXCR4 on Bone Marrow Mesenchymal Stromal Cells Contributes to Hematopoietic Stem and Progenitor Cell Defects.
Singh P; Kacena MA; Orschell CM; Pelus LM
Stem Cell Rev Rep; 2020 Aug; 16(4):684-692. PubMed ID: 32418119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
